Main menu
Edison Group
  • Home
  • Equities

    Equities

    View All Equities

    Equities by Sector

    IRLAB Therapeutics

    MCap

    SEK653m

    Last close

    SEK14.10

    ▲ 1.50 (11.90%)

    VolitionRx

    MCap

    USD51m

    Last close

    USD0.60

    ▲ 0.05 (9.82%)

    Portobello SpA

    MCap

    EUR12m

    Last close

    EUR2.38

    ▲ 0.20 (9.17%)

  • Sectors

    Sectors

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

Nanoco Group – executive interview

Nanoco Group – executive interview

Nanoco Group — 9 videos in collection

More on this equity

In this video, CEO Dr Michael Edelman begins by outlining the background to Nanoco’s patent infringement lawsuit against Samsung and gives a view of the scale of any potential settlement. He explains why Nanoco engaged a litigation finance specialist to support the legal process and how long the process could take to complete. He concludes with a discussion of the company’s cash runway and some of the customer programmes that Nanoco is working on.

Nanoco is a global leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials. Its platform includes c 770 patents and specialist manufacturing lines. Focus applications are advanced electronics, displays, lighting and bio-imaging.

< Previous
Next >

You may also be interested in these:

TMT

Nanoco – executive interview

TMT

Executive interview - Nanoco

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free